Notice of Availability of Draft Guideline; Comment Request, 28043-28044 [06-4498]
Download as PDF
Federal Register / Vol. 71, No. 93 / Monday, May 15, 2006 / Notices
Submission of Written Information
To fulfill its change describe above,
the Working Group has been conducting
a public dialogue on health care in
America through public meetings held
across the country and through
comments received on its Web site,
https://www.citizenshealthcare.gov. The
Working Group invites members of the
public to the Web site to be part of that
dialogue.
Further, the Working Group will
accept written submissions for
consideration at the Working Group
business meeting listed above. In
general, individuals or organizations
wishing to provide written information
for consideration by the Citizens’ Health
Care Working Group at this meeting
should submit information
electronically to
citizenshealth@ahrq.gov.
This notice is published less than 15
days in advance of the meeting due to
logistical difficulties.
Dated: May 10, 2006.
Carolyn M. Clancy,
Director.
[FR Doc. 06–4573 Filed 5–11–06; 1:38 pm]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Indian Health Service
jlentini on PROD1PC65 with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: National Institute for
Occupational Safety and Health
(NIOSH) Prevention of Airborne
Infections in Occupational Settings,
RFA–OH–06–002
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Prevention of
Airborne Infections in Occupational
Settings, RFA–OH–06–002.
Times And Dates:
7 p.m.–9 p.m., June 5, 2006 (Closed).
8 a.m.–5 p.m., June 6, 2006 (Closed).
8 a.m.–5 p.m., June 7, 2006 (Closed).
Place: Renaissance Mayflower Hotel,
1127 Connecticut Avenue, NW,
Washington, DC 20036, telephone (202)
776–9279.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)(4)
and (6), Title 5 U.S.C., and the
Determination of the Director,
16:54 May 12, 2006
Dated: May 8, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–7319 Filed 5–12–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Aug<31>2005
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters to Be Discussed: The meeting
will include the review, discussion, and
evaluation of research grants in
response to NIOSH RFA OH–06–002,
Prevention of Airborne Infections in
Occupational Settings.
For More Information Contact:
Bernadine B. Kuchinski, Scientific
Review Administrator, Robert A. Taft
Laboratory, 4676 Columbia Parkway,
MS C–7, Cincinnati, OH 45226, phone
(513) 533–8511, e-mail bbk1@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Jkt 208001
Health Promotion and Disease
Prevention Grant Program: Correction
ACTION:
Notice; correction.
SUMMARY: The Indian Health Service
published a document in the Federal
Register on April 5, 2006. The
document contained one error.
FOR FURTHER INFORMATION CONTACT:
Alberta Becenti, Health Promotion and
Disease Prevention Consultant, Indian
Health Service, Reyes Building, 801
Thompson Avenue, Suite 307,
Rockville, MD 20852, Telephone (301)
443–4305. (This is not a toll-free
number.)
Correction
In the Federal Register of April 5,
2006, in FR Doc. 06–3257, on page
17111, in the second column, correct by
deleting Section VIII. Other Information
in its entirety.
Dated: May 9, 2006.
Robert G. McSwain,
Deputy Director, Indian Health Service.
[FR Doc. 06–4506 Filed 5–12–06; 8:45 am]
BILLING CODE 4165–16–M
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
28043
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Notice of Availability of Draft
Guideline; Comment Request
Center for Substance Abuse
Treatment, Substance Abuse and Mental
Health Services Administration
(SAMHSA), Department of Health and
Human Services.
ACTION: Availability of Guideline—
Opportunity for Comment.
AGENCY:
SUMMARY: The Center for Substance
Abuse Treatment is seeking public
comments on the revised draft
Guidelines for the Accreditation of
Opioid Treatment Programs. These
guidelines elaborate upon the Federal
opioid treatment standards set forth
under 42 CFR part 8.
DATES: Comments should be submitted
by July 14, 2006.
ADDRESSES: The draft guideline may be
obtained directly from https://
www.dpt.samhsa.gov, or by contacting
the Division of Pharmacologic Therapy
with the information provided below.
Comments should be submitted to the
Division of Pharmacologic Therapy,
Center for Substance Abuse Treatment,
1 Choke Cherry Road, Room 2–1080,
Rockville, MD, 20857; Attention: DPT
Federal Register Representative.
Comments may also be faxed to 240–
276–2710 or e-mailed to OTP–
Guidelines@samhsa.hhs.gov. Received
comments may be seen in the office
above between 9 a.m. and 4 p.m.,
Monday through Friday.
FOR FURTHER INFORMATION CONTACT:
Sarah Crowley, Center for Substance
Abuse Treatment (CSAT), Division of
Pharmacologic Therapy, 1 Choke Cherry
Road, Room 2–1080, Rockville, MD
20857, (240–276–2704, e-mail:
Sarah.Crowley@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
Federal Regulations codified under 42
CFR part 8 set forth requirements for
opioid treatment programs (‘‘OTPs’’),
also known as methadone treatment
programs. The regulations, which were
the subject of a Final Rule published in
the Federal Register on January 17,
2001, (‘‘Final Rule’’ 66 FR 4075–4102,
January 17, 2001) include standards for
opioid treatment. OTPs are required to
provide treatment in accordance with
these standards as a basis for CSAT
certification. These standards address
patient admission requirements,
E:\FR\FM\15MYN1.SGM
15MYN1
28044
Federal Register / Vol. 71, No. 93 / Monday, May 15, 2006 / Notices
medical and counseling services, drug
testing, and other requirements.
The final rule also established an
accreditation requirement. Each OTP is
required to obtain and maintain
accreditation from an accreditation
organization approved by SAMHSA
under 42 CFR part 8. Accreditation
organizations that provide OTP
accreditation under the final rule are
required to apply for and obtain
SAMHSA approval. Under 42 CFR
8.3(a)(3), each accreditation
organization must develop a set of
accreditation elements or standards
together with a detailed discussion of
how these elements will assure that
each OTP surveyed by the accreditation
organization is meeting each for the
Federal opioid treatment standards.
The Guidelines for the Accreditation
of Opioid Treatment Programs, are
intended to guide accreditation
organizations in preparing their
accreditation standards. In addition, the
Guidelines provide useful elaborations
on the regulatory standards set forth
under 42 CFR part 8. As such, the
updated guidelines will assist both
accreditation organizations and OTPs in
complying with regulatory
requirements.
Prepared initially in 1997, Guidelines
for the Accreditation of Opioid
Treatment Programs are being updated
now to reflect new information and
research in the field of opioid assisted
treatment. CSAT convened an expert
panel to provide the draft guideline now
being circulated for comment. CSAT is
soliciting comments on the guideline
from the public, and expects comments
from OTPs, accreditation organizations,
patients, the medical community and
other interested parties.
CSAT will consider all comments
submitted by July 16, 2006; in order to
publish a revised guideline; however,
CSAT will continuously accept and
consider comments for future
consideration.
Dated: May 8, 2006.
Anna Marsh,
Director of OPS, SAMHSA.
[FR Doc. 06–4498 Filed 5–12–06; 8:45 am]
jlentini on PROD1PC65 with NOTICES
BILLING CODE 4162–20–M
VerDate Aug<31>2005
16:54 May 12, 2006
Jkt 208001
DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
Agency Information Collection
Activities: Extension of a Currently
Approved Information Collection;
Comment Request
30-Day Notice of Information
Collection Under Review: Request for
Hearing on a Decision in Naturalization
Proceedings under Section 336; Form
N–336. OMB Control No. 1615–0050.
ACTION:
The Department of Homeland
Security, U.S. Citizenship and
Immigration Services (USCIS) has
submitted the following information
collection request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995. The information collection was
previously published in the Federal
Register on February 28, 2006 at 71 FR
10049. The notice allowed for a 60-day
public comment period. No comments
were received by the USCIS on this
proposed information collection.
The purpose of this notice is to allow
an additional 30 days for public
comments. Comments are encouraged
and will be accepted until June 14,
2006. This process is conducted in
accordance with 5 CFR 1320.10.
Written comments and/or suggestions
regarding the item(s) contained in this
notice, especially regarding the
estimated public burden and associated
response time, should be directed to the
Department of Homeland Security
(DHS), USCIS, Director, Regulatory
Management Division, Clearance Office,
111 Massachusetts Avenue, 3rd Floor,
Washington, DC 20529. Comments may
also be submitted to DHS via facsimile
to 202–272–8352 or via e-mail at
rfs.regs@dhs.gov. When submitting
comments by e-mail please make sure to
add OMB Control Number 1615–0050 in
the subject box.
Written comments and suggestions
from the public and affected agencies
concerning the collection of information
should address one or more of the
following four points:
(1) Evaluate whether the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
collection of information, including the
validity of the methodology and
assumptions used;
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques, or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information Collection
(1) Type of Information Collection:
Extension of a currently approved
information collection.
(2) Title of the Form/Collection:
Request for Hearing on a Decision in
Naturalization Proceedings under
Section 336.
(3) Agency form number, if any, and
the applicable component of the
Department of Homeland Security
sponsoring the collection: Form N–336.
U.S. Citizenship and Immigration
Services.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Individuals or
Households. This form provides a
method for applicants, whose
applications for naturalization are
denied, to request a new hearing by an
immigration officer of the same or
higher rank as the denying officer.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: 7,669 responses at 2 hours and
45 minutes (2.75 hours) per response.
(6) An estimate of the total public
burden (in hours) associated with the
collection: 21,090 annual burden hours.
If you have additional comments,
suggestions, or need a copy of the
proposed information collection
instrument with instructions, or
additional information, please visit the
USCIS Web site at:
https://uscis.gov/graphics/formsfee/
forms/pra/index.htm.
If additional information is required
contact: USCIS, Regulatory Management
Division, 111 Massachusetts Avenue,
3rd Floor, Washington, DC 20529, (202)
272–8377.
Dated: May 9, 2006.
Richard A. Sloan,
Director, Regulatory Management Division,
U.S. Citizenship and Immigration Services.
[FR Doc. 06–4487 Filed 5–12–06; 8:45 am]
BILLING CODE 4410–10–M
E:\FR\FM\15MYN1.SGM
15MYN1
Agencies
[Federal Register Volume 71, Number 93 (Monday, May 15, 2006)]
[Notices]
[Pages 28043-28044]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-4498]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Notice of Availability of Draft Guideline; Comment Request
AGENCY: Center for Substance Abuse Treatment, Substance Abuse and
Mental Health Services Administration (SAMHSA), Department of Health
and Human Services.
ACTION: Availability of Guideline--Opportunity for Comment.
-----------------------------------------------------------------------
SUMMARY: The Center for Substance Abuse Treatment is seeking public
comments on the revised draft Guidelines for the Accreditation of
Opioid Treatment Programs. These guidelines elaborate upon the Federal
opioid treatment standards set forth under 42 CFR part 8.
DATES: Comments should be submitted by July 14, 2006.
ADDRESSES: The draft guideline may be obtained directly from https://
www.dpt.samhsa.gov, or by contacting the Division of Pharmacologic
Therapy with the information provided below. Comments should be
submitted to the Division of Pharmacologic Therapy, Center for
Substance Abuse Treatment, 1 Choke Cherry Road, Room 2-1080, Rockville,
MD, 20857; Attention: DPT Federal Register Representative. Comments may
also be faxed to 240-276-2710 or e-mailed to OTP-
Guidelines@samhsa.hhs.gov. Received comments may be seen in the office
above between 9 a.m. and 4 p.m., Monday through Friday.
FOR FURTHER INFORMATION CONTACT: Sarah Crowley, Center for Substance
Abuse Treatment (CSAT), Division of Pharmacologic Therapy, 1 Choke
Cherry Road, Room 2-1080, Rockville, MD 20857, (240-276-2704, e-mail:
Sarah.Crowley@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
Federal Regulations codified under 42 CFR part 8 set forth
requirements for opioid treatment programs (``OTPs''), also known as
methadone treatment programs. The regulations, which were the subject
of a Final Rule published in the Federal Register on January 17, 2001,
(``Final Rule'' 66 FR 4075-4102, January 17, 2001) include standards
for opioid treatment. OTPs are required to provide treatment in
accordance with these standards as a basis for CSAT certification.
These standards address patient admission requirements,
[[Page 28044]]
medical and counseling services, drug testing, and other requirements.
The final rule also established an accreditation requirement. Each
OTP is required to obtain and maintain accreditation from an
accreditation organization approved by SAMHSA under 42 CFR part 8.
Accreditation organizations that provide OTP accreditation under the
final rule are required to apply for and obtain SAMHSA approval. Under
42 CFR 8.3(a)(3), each accreditation organization must develop a set of
accreditation elements or standards together with a detailed discussion
of how these elements will assure that each OTP surveyed by the
accreditation organization is meeting each for the Federal opioid
treatment standards.
The Guidelines for the Accreditation of Opioid Treatment Programs,
are intended to guide accreditation organizations in preparing their
accreditation standards. In addition, the Guidelines provide useful
elaborations on the regulatory standards set forth under 42 CFR part 8.
As such, the updated guidelines will assist both accreditation
organizations and OTPs in complying with regulatory requirements.
Prepared initially in 1997, Guidelines for the Accreditation of
Opioid Treatment Programs are being updated now to reflect new
information and research in the field of opioid assisted treatment.
CSAT convened an expert panel to provide the draft guideline now being
circulated for comment. CSAT is soliciting comments on the guideline
from the public, and expects comments from OTPs, accreditation
organizations, patients, the medical community and other interested
parties.
CSAT will consider all comments submitted by July 16, 2006; in
order to publish a revised guideline; however, CSAT will continuously
accept and consider comments for future consideration.
Dated: May 8, 2006.
Anna Marsh,
Director of OPS, SAMHSA.
[FR Doc. 06-4498 Filed 5-12-06; 8:45 am]
BILLING CODE 4162-20-M